Skip to main content
. 2021 Apr 7;16:163. doi: 10.1186/s13023-021-01812-6

Table 1.

Patients and relatives socio-demographic characteristics and patients’ clinical variables

Patients (N = 141) Relatives (N = 69)
N % N %
Socio-demographic characteristics
 Gender
  Males 106 75.2 15 21.7
  Females 35 24.8 54 78.3
 Age, mean ± SD 66.1 ± 11.09 57.2 ± 11.8
 Marital status
  Free 34 25.2 9 10.5
  Married 101 74.8 60 89.6
 Education
  Primary school 18 14.3 10 14.7
  Secondary school 42 33.3 14 20.6
  High school 44 34.9 32 47.1
  University 22 17.5 12 17.7
 Employed, yes 41 29.5 32 47.1
 Relationship with the patient
  Spouse 51 75.0
  Other 17 25.0
 Daily hours spent in caregiving, mean ± SD 8.1 ± 9.7
Clinical variables
 Mutation
  Val30Met 39 27.6
  Phe64Leu 33 23.4
  Glu89Gln 25 17.7
  Ile68Leu 14 9.9
  Val122Ile 7 5
  Tyr78Phe 7 5
  Thr49Ala 6 4.3
  Other (n. 9) 10 7.1
 Phenotype
  ATTRv-PN 111 78.7
  ATTRv-CM 30 21.3
 ATTRv stage
  0 6 4.3
  1 75 53.2
  2 42 29.8
  3 18 12.8
Age at symptom onset, mean ± SD 59.8 ± 11.8
Length of symptom in years, mean ± SD 6.2 ± 4.2

Mutation nomenclature follows the traditional classification which refers to the TTR protein (NCBI Reference Sequence: NP_000362.1; chromosome 18, NC_000018.10) without the first 20 amino acids of the leader peptide. For example, Val30Met corresponds to p.(Val50Met) if one follows the Human Genome Variation Society (HGVS) nomenclature (https://www.hgvs.org/content/guidelines)